Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

MAA-MED MEDANSH

Class 5Status: Abandoned
Application Number6553750
Trademark Status
Abandoned
Trademark Class5
Application Date2024-07-31
Proprietor NameMEDANSH PHARMACEUTICALS
Appropriate OfficeCHENNAI
StateTELANGANA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameNEWTON REGINALD[25853]
Agent AddressNo 6, Dhanammal Street Spurtank Road Chetpet Chennai - 600031
Goods And Services Details[CLASS : 5] Tablets [pharmaceuticals], Pills being pharmaceuticals, Pharmaceutical substances and preparations, Nutraceuticals for therapeutic or medical purposes, Nutraceutical preparations for humans, Medicinal sprays, Medicinal preparations and substances, Nutraceuticals for medical purposes

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
MAA-MED MEDANSH5Abandoned

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about MAA MED MEDANSH.

The current status of trademark application 6553750 for MAA-MED MEDANSH is Abandoned.
MAA-MED MEDANSH is registered under trademark class 5.
The proprietor of MAA-MED MEDANSH is MEDANSH PHARMACEUTICALS.
Trademark application 6553750 for MAA-MED MEDANSH was filed on 2024-07-31.